ロード中...
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
This study aimed to investigate whether pre-chemotherapy anti-mullerian hormone (AMH) is a biomarker for chemotherapy-related amenorrhea (CRA) in breast cancer patients. A multicenter randomized controlled trial, ECOG5103, assigned patients with early stage breast cancer to standard doxorubicin-cycl...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334112/ https://ncbi.nlm.nih.gov/pubmed/24584876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2891-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|